Eleven Biotherapeutics extends gains

Shares of Eleven Biotherapeutics (Nasdaq: EBIO) continued to climb by gaining 64 cents to close at $5.35.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.